chr11-121113730-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_005422.4(TECTA):​c.790+12C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00674 in 1,612,826 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). The gene TECTA is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.0053 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0069 ( 46 hom. )

Consequence

TECTA
NM_005422.4 intron

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 0.658

Publications

2 publications found
Variant links:
Genes affected
TECTA (HGNC:11720): (tectorin alpha) The tectorial membrane is an extracellular matrix of the inner ear that contacts the stereocilia bundles of specialized sensory hair cells. Sound induces movement of these hair cells relative to the tectorial membrane, deflects the stereocilia, and leads to fluctuations in hair-cell membrane potential, transducing sound into electrical signals. Alpha-tectorin is one of the major noncollagenous components of the tectorial membrane. Mutations in the TECTA gene have been shown to be responsible for autosomal dominant nonsyndromic hearing impairment and a recessive form of sensorineural pre-lingual non-syndromic deafness. [provided by RefSeq, Jul 2008]
TBCEL-TECTA (HGNC:54857): (TBCEL-TECTA readthrough) Predicted to enable alpha-tubulin binding activity. Predicted to be involved in microtubule cytoskeleton organization; post-chaperonin tubulin folding pathway; and tubulin complex assembly. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 11-121113730-C-T is Benign according to our data. Variant chr11-121113730-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 178637.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00535 (814/152240) while in subpopulation NFE AF = 0.00891 (606/68018). AF 95% confidence interval is 0.00832. There are 7 homozygotes in GnomAd4. There are 379 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005422.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TECTA
NM_005422.4
MANE Select
c.790+12C>T
intron
N/ANP_005413.2O75443
TBCEL-TECTA
NM_001378761.1
c.1747+12C>T
intron
N/ANP_001365690.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TECTA
ENST00000392793.6
TSL:5 MANE Select
c.790+12C>T
intron
N/AENSP00000376543.1O75443
TECTA
ENST00000264037.2
TSL:1
c.790+12C>T
intron
N/AENSP00000264037.2O75443
TECTA
ENST00000642222.1
c.790+12C>T
intron
N/AENSP00000493855.1A0A2R8YDL0

Frequencies

GnomAD3 genomes
AF:
0.00535
AC:
814
AN:
152122
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00130
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00990
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00891
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00482
AC:
1205
AN:
250192
AF XY:
0.00468
show subpopulations
Gnomad AFR exome
AF:
0.00136
Gnomad AMR exome
AF:
0.00168
Gnomad ASJ exome
AF:
0.00160
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0104
Gnomad NFE exome
AF:
0.00740
Gnomad OTH exome
AF:
0.00393
GnomAD4 exome
AF:
0.00688
AC:
10056
AN:
1460586
Hom.:
46
Cov.:
32
AF XY:
0.00674
AC XY:
4896
AN XY:
726540
show subpopulations
African (AFR)
AF:
0.00117
AC:
39
AN:
33450
American (AMR)
AF:
0.00181
AC:
81
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.00191
AC:
50
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000719
AC:
62
AN:
86192
European-Finnish (FIN)
AF:
0.0100
AC:
532
AN:
53122
Middle Eastern (MID)
AF:
0.000588
AC:
3
AN:
5102
European-Non Finnish (NFE)
AF:
0.00805
AC:
8951
AN:
1111878
Other (OTH)
AF:
0.00560
AC:
338
AN:
60312
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
570
1139
1709
2278
2848
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
320
640
960
1280
1600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00535
AC:
814
AN:
152240
Hom.:
7
Cov.:
32
AF XY:
0.00509
AC XY:
379
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.00130
AC:
54
AN:
41552
American (AMR)
AF:
0.00190
AC:
29
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4818
European-Finnish (FIN)
AF:
0.00990
AC:
105
AN:
10602
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00891
AC:
606
AN:
68018
Other (OTH)
AF:
0.00237
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
42
84
126
168
210
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00818
Hom.:
2
Bravo
AF:
0.00425
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
not specified (2)
-
-
1
Autosomal dominant nonsyndromic hearing loss 12 (1)
-
1
-
Autosomal recessive nonsyndromic hearing loss 21 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
16
DANN
Benign
0.73
PhyloP100
0.66
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138644808; hg19: chr11-120984439; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.